Skip to main content
. 2021 Jul 2;14:4023–4037. doi: 10.2147/OTT.S312904

Figure 5.

Figure 5

Grades of CRS, ICANS and hematological toxicity in the two kinds of CAR-T cell therapy. (A). There was no different of the CRS grades in the two kinds of therapy. (B). There was no different of the ICANS grades in the two kinds of therapy. (C-E). There was no different of the hematological toxicity grades in the two kinds of therapies.